You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,705,789


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,705,789
Title: Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids
Abstract:The invention relates to solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids, and in particular both ready-to-use injection and/or infusion solutions and dosage forms which can be converted into such injection and/or infusion solutions before use. The solutions according to the invention are characterized in that, besides the lactic acid salts of the active substance and, if appropriate, customary auxiliaries, they additionally contain at least one acid which does not lead to precipitates, in particular lactic acid.
Inventor(s): Grohe; Klaus (Odenthal, DE), Lammens; Robert (Leverkusen, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/644,834
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,705,789: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies to protect their intellectual property. The United States Patent 4,705,789, though not specifically detailed in the provided sources, can be analyzed through a general understanding of patent law, the process of determining patent scope and claims, and the importance of accurate inventorship.

Patent Law in the United States

Patents in the U.S. are governed by the Patent Act (35 U.S.C.), which establishes the United States Patent and Trademark Office (USPTO) as the agency responsible for granting patents and registering trademarks[4][5].

Types of Patents

The most common type of patent is the utility patent, which has a duration of 20 years from the date of filing but is not enforceable until the day of issuance. Other types include design patents and plant patents[4].

Patent Application and Examination Process

To obtain a patent, an applicant must submit a patent application to the USPTO, where it is reviewed by an examiner to determine if the invention is patentable. This process involves evaluating the novelty, non-obviousness, and usefulness of the invention[4].

Determining Inventorship

Inventorship is a critical aspect of patent law. The true and only inventors must be listed on the patent application. Conception of the idea and reduction to practice are key steps in determining inventorship. Conception is complete when the idea is sufficiently definite and permanent to permit one with ordinary skill in the field to reduce it to practice without undue experimentation[2].

Patent Claims and Scope

Patent claims define the scope of the invention and are crucial for determining what is protected by the patent. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics. This dataset helps in understanding the dependency relationships between claims and measuring patent scope[3].

Claim Structure

Patent claims are typically structured in a hierarchical manner, with independent claims standing alone and dependent claims referring back to other claims. The scope of a patent is largely defined by its independent claims, which set the broad boundaries of what is protected[3].

Claim Types

  • Independent Claims: These claims stand alone and do not refer to any other claims.
  • Dependent Claims: These claims refer back to other claims and further limit the scope of the invention.

Claim Analysis

Analyzing the claims of a patent involves understanding the language and scope of each claim. This includes identifying key terms, understanding the relationships between claims, and determining the overall breadth of protection provided by the patent.

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the same inventor or assignee from obtaining multiple patents for the same invention. This is particularly relevant when dealing with continuation-in-part patents or patents that have been granted Patent Term Adjustments (PTA). The Federal Circuit has ruled that ODP analysis must be performed on patents that have been granted PTA, ensuring that the expiration dates of related patents are aligned[1].

Patent Term Adjustments and Extensions

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE) can affect the duration of a patent. PTA is granted for USPTO delays during prosecution, while PTE is granted for regulatory review periods. These adjustments and extensions can impact the overall lifespan of a patent and must be considered when analyzing the patent landscape[1].

Case Study: In re Cellect, LLC

The case of In re Cellect, LLC highlights the complexities of ODP and patent term adjustments. Here, multiple patents within the same family were subject to ODP analysis, and the court had to determine whether the patents should be considered based on their original expiration dates or the dates adjusted by PTA. This case underscores the importance of careful analysis when dealing with related patents and their expiration dates[1].

Key Takeaways

  • Accurate Inventorship: Correctly identifying the true and only inventors is crucial for the validity of a patent.
  • Claim Analysis: Understanding the structure and scope of patent claims is essential for determining the protection provided by a patent.
  • ODP and Patent Term Adjustments: These factors can significantly impact the validity and duration of related patents.
  • Patent Scope: Analyzing claim dependencies and statistics helps in measuring the breadth of protection.

FAQs

What is the importance of accurate inventorship in patent applications?

Accurate inventorship is crucial because incorrectly listing inventors can lead to the invalidation of the patent. Only the true and only inventors should be listed to ensure the patent remains enforceable[2].

How do Patent Term Adjustments (PTA) affect the duration of a patent?

PTA is granted for USPTO delays during prosecution, extending the patent term to compensate for these delays. This adjustment can impact the overall lifespan of a patent and must be considered in ODP analyses[1].

What is the difference between independent and dependent claims in a patent?

Independent claims stand alone and define the broad boundaries of the invention, while dependent claims refer back to other claims and further limit the scope of the invention[3].

How does the Patent Claims Research Dataset help in understanding patent scope?

The dataset provides detailed information on claims, including claim-level statistics and document-level statistics, helping to measure patent scope and understand claim dependencies[3].

What is Obviousness-Type Double Patenting (ODP), and why is it important?

ODP prevents the same inventor or assignee from obtaining multiple patents for the same invention. It is important to ensure that related patents do not overlap in scope and to align their expiration dates[1].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Determining Inventorship for US Patent Applications, Oregon State University.
  3. Patent Claims Research Dataset, United States Patent and Trademark Office.
  4. Patent Law in the United States, BitLaw.
  5. U.S. Patent and Trademark Office (USPTO), USAGov.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,705,789

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,705,789

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3333719Sep 17, 1983

International Family Members for US Patent 4,705,789

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 38332 ⤷  Subscribe
Australia 3297684 ⤷  Subscribe
Australia 562507 ⤷  Subscribe
Canada 1228547 ⤷  Subscribe
German Democratic Republic 227882 ⤷  Subscribe
Germany 3333719 ⤷  Subscribe
Germany 3474915 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.